4.0 Article

Chemical shift assignment of the ataxin-1 AXH domain in complex with a CIC ligand peptide

Journal

BIOMOLECULAR NMR ASSIGNMENTS
Volume 8, Issue 2, Pages 325-327

Publisher

SPRINGER
DOI: 10.1007/s12104-013-9509-z

Keywords

AXH; SCA1; Poly-glutamine; Conformational switch; CIC; Transcriptional repressor

Funding

  1. Medical Research Council [MC_PC_13054, MC_U117533887, MC_U117584256] Funding Source: Medline
  2. MRC [MC_U117584256, MC_U117533887, MC_PC_13054] Funding Source: UKRI
  3. Medical Research Council [MC_U117533887, MC_PC_13054, MC_U117584256] Funding Source: researchfish

Ask authors/readers for more resources

Ataxin-1 is the protein responsible for the genetically-inherited neurodegenerative disease spinocerebellar ataxia type-1 linked to the expansion of a polyglutamine tract within the protein sequence. The AXH domain of ataxin-1 is essential for the protein to function as a transcriptional co-repressor and mediates the majority of the interactions of ataxin-1 with cellular partners, mainly transcriptional regulators. One of the best characterized ataxin-1 functional partners is Capicua (CIC), a transcriptional repressor involved in signalling pathways that regulate mammalian development, tumorigenesis and, through the interaction with ataxin-1, also neurodegeneration. Complex formation of ataxin-1 with CIC is important both for the function of the wild-type protein and for pathogenesis as transcriptional disregulation is observed since the early stages of the development of the disease. Here we report the H-1, C-13 and N-15 backbone and side-chain chemical shift assignments of the human ataxin-1 AXH domain in complex with a CIC ligand-peptide.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available